Medy Tox Inc operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Medy Tox Inc with three other
companies in this sector in South Korea:
sales of 182.39 billion Korean Won [US$153.21 million]
of which 51%
Cell Biotech Co ., Limited.
(62.54 billion Korean Won [US$52.54 million]
of which 89%
was Finished Products), and
G-treeBNT Co Ltd
(46.36 billion Korean Won [US$38.94 million]
of which 61%
During the year ended December of 2018, sales at
Medy Tox Inc were 205.44 billion Korean Won (US$172.57 million).
increase of 13.4%
versus 2017, when the company's sales were 181.24 billion Korean Won.
This was the fifth consecutive year of sales increases at Medy Tox Inc
(and since 2013, sales have increased a total of 425%).